The Dual Role of Amyloid Beta-Peptide in Oxidative Stress and Inflammation: Unveiling Their Connections in Alzheimer’s Disease Etiopathology
Open Access
- 8 October 2024
- journal article
- review article
- Published by MDPI AG in Antioxidants
- Vol. 13 (10) , 1208
Abstract
Alzheimer’s disease (AD) is a progressive neurodegenerative disease, and it is currently the seventh leading cause of death worldwide. It is characterized by the extracellular aggregation of the amyloid β-peptide (Aβ) into oligomers and fibrils that cause synaptotoxicity and neuronal death. Aβ exhibits a dual role in promoting oxidative stress and inflammation. This review aims to unravel the intricate connection between these processes and their contribution to AD progression. The review delves into oxidative stress in AD, focusing on the involvement of metals, mitochondrial dysfunction, and biomolecule oxidation. The distinct yet overlapping concept of nitro-oxidative stress is also discussed, detailing the roles of nitric oxide, mitochondrial perturbations, and their cumulative impact on Aβ production and neurotoxicity. Inflammation is examined through astroglia and microglia function, elucidating their response to Aβ and their contribution to oxidative stress within the AD brain. The blood–brain barrier and oligodendrocytes are also considered in the context of AD pathophysiology. We also review current diagnostic methodologies and emerging therapeutic strategies aimed at mitigating oxidative stress and inflammation, thereby offering potential treatments for halting or slowing AD progression. This comprehensive synthesis underscores the pivotal role of Aβ in bridging oxidative stress and inflammation, advancing our understanding of AD and informing future research and treatment paradigms.Keywords
Funding Information
- Spanish Ministry of Science, Innovation and Universities (MCIU) (PID2020-117691RB-I00/AEI/10.13039/501100011033, PID2023-149767OB-I00, MCIU/AEI/10.13039/501100011033, CEX2018-000792-M)
- Agencia Estatal de Investigación (AEI) plus European Social Fund Plus (FSE+) (PID2020-117691RB-I00/AEI/10.13039/501100011033, PID2023-149767OB-I00, MCIU/AEI/10.13039/501100011033, CEX2018-000792-M)
- Maria de Maeztu Programme (PID2020-117691RB-I00/AEI/10.13039/501100011033, PID2023-149767OB-I00, MCIU/AEI/10.13039/501100011033, CEX2018-000792-M)
This publication has 348 references indexed in Scilit:
- DNA damage‐induced neuroinflammation in neurodegenerative diseaseAlzheimer's & Dementia, 2021
- Regional brain iron associated with deterioration in Alzheimer's disease: A large cohort study and theoretical significanceAlzheimer's & Dementia, 2021
- Homocysteine exacerbates β‐amyloid pathology, tau pathology, and cognitive deficit in a mouse model of Alzheimer disease with plaques and tanglesAnnals of Neurology, 2014
- Glial influence on the blood brain barrierGlia, 2013
- Modification of γ‐secretase by nitrosative stress links neuronal ageing to sporadic Alzheimer's diseaseEMBO Molecular Medicine, 2012
- Genome-wide Analysis of Genetic Loci Associated With Alzheimer DiseaseJAMA, 2010
- Reduced Risk of Alzheimer Disease in Users of Antioxidant Vitamin SupplementsArchives of Neurology, 2004
- Intracellular signaling in M‐CSF‐induced microglia activation: Role of Iba1Glia, 2002
- Dietary Intake of Antioxidant Nutrients and the Risk of Incident Alzheimer Disease in a Biracial Community StudyJAMA, 2002
- Oxidative damage to mitochondrial DNA is increased in Alzheimer's diseaseAnnals of Neurology, 1994